BECN1 and cancer: BRAF deacetylation, vemurafenib activity and resistance, stage- and cancer-dependent regulation of cell cycle, apoptosis, and metastasis, induction of autophagy (Beclin 1 deacetylation), proliferation upon SIRT1 upregulation, cancer-dependent senescence regulation